脂毒性
死孢子体1
脂肪性肝炎
坦克结合激酶1
磷酸化
蛋白激酶A
自噬
内科学
泛素
泛素连接酶
脂肪肝
内分泌学
细胞生物学
癌症研究
化学
生物
生物化学
医学
细胞凋亡
胰岛素抵抗
细胞周期蛋白依赖激酶2
疾病
胰岛素
基因
作者
Chun‐Seok Cho,Hwan‐Woo Park,Allison Ho,Ian Semple,Bo Young Kim,Insook Jang,Haeli Park,Shannon M. Reilly,Alan R. Saltiel,Jun Hee Lee
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2017-12-18
卷期号:68 (4): 1331-1346
被引量:91
摘要
Obesity commonly leads to hepatic steatosis, which often provokes lipotoxic injuries to hepatocytes that cause nonalcoholic steatohepatitis (NASH). NASH, in turn, is associated with the accumulation of insoluble protein aggregates that are composed of ubiquitinated proteins and ubiquitin adaptor p62/sequestosome 1 (SQSTM1). Formation of p62 inclusions in hepatocytes is the critical marker that distinguishes simple fatty liver from NASH and predicts a poor prognostic outcome for subsequent liver carcinogenesis. However, the molecular mechanism by which lipotoxicity induces protein aggregation is currently unknown. Here, we show that, upon saturated fatty acid‐induced lipotoxicity, TANK binding kinase 1 (TBK1) is activated and phosphorylates p62. TBK1‐mediated p62 phosphorylation is important for lipotoxicity‐induced aggregation of ubiquitinated proteins and formation of large protein inclusions in hepatocytes. In addition, cyclic GMP‐AMP synthase (cGAS) and stimulator of interferon genes (STING), upstream regulators of TBK1, are involved in lipotoxic activation of TBK1 and subsequent p62 phosphorylation in hepatocytes. Furthermore, TBK1 inhibition prevented formation of ubiquitin‐p62 aggregates not only in cultured hepatocytes, but also in mouse models of obesity and NASH. Conclusion : These results suggest that lipotoxic activation of TBK1 and subsequent p62 phosphorylation are critical steps in the NASH pathology of protein inclusion accumulation in hepatocytes. This mechanism can provide an explanation for how hypernutrition and obesity promote the development of severe liver pathologies, such as steatohepatitis and liver cancer, by facilitating the formation of p62 inclusions. (H epatology 2018).
科研通智能强力驱动
Strongly Powered by AbleSci AI